H. Lundbeck

Arlington, Massachusetts, U.S., September 11, 2026 Eloxx Pharmaceuticals has announced that the first two patients have been dosed in...

Copenhagen, Denmark, September 10, 2026 H. Lundbeck A/S has announced that the U.S. Food and Drug Administration (FDA) has...